serogroup b meningococcal vaccine (Trumenba) Report issue

Vaccine Approved FDA Breakthrough Therapy FDA

Active Ingredient History

NOW
  • Now

More Chemistry
  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: Missing data
  • Availability: Missing data
  • Delivery Methods: Missing data
  • Pro Drug: Missing data
bivalent rlp2086 | meningococcal b vaccine | mnb rlp2086 | mnb rlp8026 | neisseria meningitidis serogroup b fhbp (recombinant lipidated fhbp (factor h binding protein)) subfamily a; neisseria meningitidis serogroup b fhbp (recombinant lipidated fhbp (factor h binding protein)) subfamily b | recombinant meningococcal b vaccine | rlp2086 | serogroup b meningococcal vaccine | trumenba vaccine

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue